Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report

GUO Xinglin; SHAO Jianzhu; JING Jing; XIAO Mingzhong; XUE Chongxiang; LI Qingwei; ZHANG Yanjiao; YAO Chensi; ZHAO Xuefei; CHEN Keyu; YANG Yingying; LI Xiuyang; BAI Yusheng

doi:10.13288/j.11-2166/r.2023.23.016

您当前的位置：

首页 >

文章列表页 >

Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report

更新时间：2023-11-24

- Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report
  增强出版
- Journal of Traditional Chinese Medicine Vol. 64, Issue 23, Pages: 2466-2470(2023)
- 作者机构：
  
  1.天津中医药大学第一附属医院/国家中医针灸临床医学研究中心，天津市西青区昌凌路88号，300381
  2.天津市北辰区西堤头镇社区卫生服务中心
  3.新疆医科大学附属中医医院
  4.湖北省中医院
  5.北京中医药大学
  6.中国中医科学院广安门医院
  7.中日友好医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2023.23.016
  CLC：
- Received：27 March 2023，
  
  Revised：2023-09-22，
  
  Published：02 December 2023
- 稿件说明：
移动端阅览
郭杏林,邵建柱,荆晶等.中西医结合治疗急性淋巴细胞白血病合并新型冠状病毒感染（重型）恢复期患者1例[J].中医杂志,2023,64(23):2466-2470.

GUO Xinglin,SHAO Jianzhu,JING Jing,et al.Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report[J].Journal of Traditional Chinese Medicine,2023,64(23):2466-2470.
郭杏林,邵建柱,荆晶等.中西医结合治疗急性淋巴细胞白血病合并新型冠状病毒感染（重型）恢复期患者1例[J].中医杂志,2023,64(23):2466-2470. DOI： 10.13288/j.11-2166/r.2023.23.016.

GUO Xinglin,SHAO Jianzhu,JING Jing,et al.Integrated Traditional Chinese and Western Medicine Treatment for Acute Lymphoblastic Leukemia Complicated with Severe COVID-19 in Recovery Stage： A Case Report[J].Journal of Traditional Chinese Medicine,2023,64(23):2466-2470. DOI： 10.13288/j.11-2166/r.2023.23.016.

摘要

报道1例急性淋巴细胞白血病合并新型冠状病毒感染（重型）恢复期的中西医结合治疗病案，以期为相关疾病的临床诊疗提供思路。患者急性淋巴细胞白血病化疗后骨髓抑制期感染新型冠状病毒，西医以抗感染及对症、支持治疗为主，进入恢复期后考虑化疗后病史及病势转归情况，整体辨证为气阴两虚、痰瘀互结证，基于“态靶结合”的辨治策略选方用药，厘清“虚态”“病靶”“症靶”，在西医治疗基础上予生脉散合复方浙贝颗粒组方加减以益气养阴扶正、养血凉血，最终获得满意疗效。

Abstract

This paper reported a case of severe COVID-19 in the recovery stage with acute lymphoblastic leukemia treated by integrated traditional Chinese and western medicine， with the intention of shedding light on the clinical diagnosis and treatment of similar conditions. The patient， who had acute lymphoblastic leukemia， developed COVID-19 infection during the bone marrow suppression period after chemotherapy. Treatment with western medicine was mainly anti-infection， symptomatic management， and supportive care. During the recovery stage， considering the patient's chemotherapy history and disease progression， the overall syndrome was identified as deficiency of both

and

yin

and binding of phlegm and blood. Based on the “state-target” combined treatment strategy， herbal prescriptions were selected and modified to address the “deficiency state”， “disease target”， and “symptom target”. In addition to western medicine， the patient was administered with

Shengmai Powder

（生脉散） and

Compound Zhebei Granules

（复方浙贝颗粒） in its modifications to boost

， nourish

yin

， and reinforce healthy

， nourish and cool the blood， ultimately achieving satisfactory therapeutic effects.

关键词

Keywords

references

KÜNZ T ， HAUSWIRTH AW ， HETZENAUER G ， et al . Changing landscape in the treatment of adult acute lymphoblastic leukemia （ALL）［J］. Cancers （Basel）， 2022 ， 14 （ 17 ）： 4290 .

SINGHAL T . A review of coronavirus disease-2019 （COVID-19）［J］. Indian J Pediatr ， 2020 ， 87 （ 4 ）： 281 - 286 .

SINGH S ， SINGH J ， PAUL D ， et al . Treatment of acute leukemia during COVID-19： focused review of evidence ［J］. Clin Lymphoma Myeloma Leuk ， 2021 ， 21 （ 5 ）： 289 - 294 .

中国临床肿瘤学会指南工作委员会 . 中国临床肿瘤学会（CSCO）恶性血液病诊疗指南2022 ［M］. 北京：人民卫生出版社， 2022 ： 21 - 45 .

蓝海，侯丽，郎海燕，等 . 常见血液病的中医分类与命名［J］. 中医杂志， 2019 ， 60 （ 9 ）： 750 - 753，778 .

李冬云，陈信义，侯丽，等 . 从痰瘀论治难治性白血病［J］. 中国中医基础医学杂志， 2009 ， 15 （ 5 ）： 365 - 367 .

王珺，陈信义，赖宗浪，等 . 复方浙贝颗粒辅助化疗改善难治性急性白血病患者症状的临床观察［J］. 北京中医药， 2013 ， 32 （ 11 ）： 833 - 835 .

李冬云，黄山，陈信义，等 . 复方浙贝颗粒对难治性急性白血病患者生存期影响的临床观察［J］. 中国中西医结合杂志， 2012 ， 32 （ 7 ）： 889 - 891 .

赵绍琴 . 中医中药治疗白血病的新认识［J］. 中医药研究， 1992 ， 8 （ 2 ）： 11 - 12 .

仝小林，李修洋，赵林华，等 . 从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略［J］. 中医杂志， 2020 ， 61 （ 6 ）： 465 - 470，553 .

国家卫生健康委员会办公厅，国家中医药管理局综合司 . 关于印发新型冠状病毒感染诊疗方案（试行第十版）的通知［EB/OL］.（ 2023-01-05 ）［ 2023-09-21 ］. http：//www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm？id=32de5b2ff9bf4eaa88e75bdf7223a65a http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=32de5b2ff9bf4eaa88e75bdf7223a65a .

董立硕，李青伟，张莉莉，等 . 基于态靶辨治选方用药的思路与临床应用［J］. 中医杂志， 2023 ， 64 （ 3 ）： 250 - 254 .

仝小林，何莉莎，赵林华 . 论“态靶因果”中医临床辨治方略［J］. 中医杂志， 2015 ， 56 （ 17 ）： 1441 - 1444 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The Development of Chinese Herbal Formulae for Non-severe COVID-19 Based on Artificial Intelligence Technology and Investigation of Its Action Mechanisms

Integration of Traditional Chinese and Western Medicine in the Treatment of Liver Transplant Patient with Severe COVID-19： A Case Report

Treatment of Critical COVID-19 Case Complicated with Multiple Organ Dysfunction based on “Cold-dampness Entering Ying （营）” Theory： A Case Report

Academician TONG Xiaolin's Understanding and Experience in Treating Severe Cases of COVID-19

Contribution of Traditional Chinese Medicine Combined with Conventional Medicine Treatment for a Long-Term Survivor of Heart Transplant with Severe COVID-19： A Case Report

Related Author

LIU Qingquan

XIE Lan

CHENG Jing

ZHANG Zhi

GUO Hongyan

CAO Hongmei

LIU Tengwen

YAN Di

Related Institution

Beijing Hospital of Traditional Chinese Medicine，Capital Medical University

Beijing CapitalBio Pharma Co.， Ltd.

School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine

National Engineering Research Center for Beijing Biochip Technology

Medical Systems Biology Research Center， School of Medicine， Tsinghua University

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰